gip and glp 1 receptor agonist Understand GLP-1/GIP Dual Tirzepatide Its Effect on Current Weight Loss Therapy The dual glucose-dependent insulinotropic polypeptide
Description
Sun Y, Liu Y, Dian Y, Zeng F, Deng G, Lei S
The authors also establish that GLP-1 agonists increase the risk of adverse gastrointestinal events, including diarrhoea and nausea in children, in line with their known side effects in adults
Effect of renal impairment on the pharmacokinetics of a single oral dose of danuglipron in participants with type 2 diabetes
Registration: Research in context What is already known about this subject
Doses may be lowered temporarily until symptoms resolve
N., Wharton, S., Connery, L., Alves, B., et al
